Available from, as of September 13, 2018: For more Metabolism/Metabolites (Complete) data for 13-cis-Retinoic acid (6 total), please visit the HSDB record page
Complex manufacturing: GLP-1 medications are made from recombinant DNA technology, which is a more complicated and expensive manufacturing process than tablets and capsules
To incentivize improvements in quality and care coordination, CMS will assess the clinician's performance on those measures and activities relative to their peers, who are also participants of the model and of a similar specialty type treating the same chronic condition
Below, we explore how indication expansion is unfolding and what it means for clinical development in 2026 and beyond in obesity, oncology and cell and gene therapy
10.1111/j.1440-1843.2007.01034.x
Your gastroenterologist and weight loss provider should review your disease history, current medications, and recent imaging before approval